Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarker Jeopardy.
Kurtin SE, Henglefelt A, Price A. Kurtin SE, et al. Among authors: price a. J Adv Pract Oncol. 2021 Apr;12(3):285-288. doi: 10.6004/jadpro.2021.12.3.13. Epub 2021 Apr 1. J Adv Pract Oncol. 2021. PMID: 34084576 Free PMC article.
Kurtin, PhD, ANP-C, AOCN, led the session, and was joined by Alyssa Henglefelt, PharmD, BCOP, and Allyson Price, PA-C. Using a Jeopardy format, they identified specific biomarkers while discussing targeted therapies and class effects APs should be aware of....
Kurtin, PhD, ANP-C, AOCN, led the session, and was joined by Alyssa Henglefelt, PharmD, BCOP, and Allyson Price, PA-C. Using a …
The Role of the Advanced Practitioner in Enhancing Outcomes.
Nix NM, Price A. Nix NM, et al. Among authors: price a. J Adv Pract Oncol. 2019 Nov-Dec;10(Suppl 4):19-22. doi: 10.6004/jadpro.2019.10.8.14. Epub 2019 Nov 1. J Adv Pract Oncol. 2019. PMID: 33537167 Free PMC article. Review.
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia.
Abou Dalle I, Ghorab A, Patel K, Wang X, Hwang H, Cortes J, Issa GC, Yalniz F, Sasaki K, Chihara D, Price A, Kadia T, Pemmaraju N, Daver N, DiNardo C, Ravandi F, Kantarjian HM, Borthakur G. Abou Dalle I, et al. Among authors: price a. Blood Cancer J. 2020 May 4;10(5):48. doi: 10.1038/s41408-020-0318-1. Blood Cancer J. 2020. PMID: 32366841 Free PMC article.
High certainty evidence is stable and trustworthy, whereas evidence of moderate or lower certainty may be equally prone to being unstable.
Djulbegovic B, Koletsi D, Hozo I, Price A, Martimbianco ALC, Riera R, Nadanovsky P, Dos Santos APP, Pandis N, Pacheco RL, Fontes LE, Seehra J, Ahmed M, Yao L, Nunan D, Hemkens LG. Djulbegovic B, et al. Among authors: price a. J Clin Epidemiol. 2024 May 11:111392. doi: 10.1016/j.jclinepi.2024.111392. Online ahead of print. J Clin Epidemiol. 2024. PMID: 38740313
A randomized trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment.
Waters V, Shaw M, Perrem L, Quon BS, Tullis E, Solomon M, Rayment JH, Lavoie A, Tse SM, Daigneault P, Bilodeau L, Price A, Nicholson M, Chin M, Parkins M, McKinney ML, Tam JS, Stanojevic S, Grasemann H, Ratjen F; PIPE Study Investigators. Waters V, et al. Among authors: price a. Eur Respir J. 2024 May 2:2302278. doi: 10.1183/13993003.02278-2023. Online ahead of print. Eur Respir J. 2024. PMID: 38697648
2,743 results